Effects of liraglutide on weight, satiation, and gastric functions in obesity: A randomised, placebo-controlled pilot trial
Follow-up testing at 4 and 12 weeks helps clinicians track changes and adjust preventive medications if needed
44% of baby boomers see improved blood sugar control on GLP-1s, compared to 30% of Gen X and 15% of Gen Z
This gradual approach prevents the nausea or extreme fullness that can occur when carbohydrate portions exceed your current medication-adjusted capacity
On tirzepatide, these effects are amplified because GLP-1 medications alter alcohol absorption and metabolism
Specification and emulation of the reference trial including our expansion studies are stated in the Supplementary Information, following the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline (Supplementary Tables 2729) 42